Improving research for prostate cancer survivorship: A statement from the Survivorship Research in Prostate Cancer (SuRECaP) working group.

Journal Article (Journal Article;Review)

Survivorship care for patients with prostate cancer requires careful consideration of unique disease-specific factors, including the prolonged natural disease history, the potential for competing health risks, and the consequences of long-term androgen deprivation therapy. However, current prostate cancer survivorship research is unfortunately limited by the lack of a robust supportive evidence base, variability in the definitions and measurement of survivorship outcomes, and a heavy reliance on expert opinion. As a result, the conduct of quality prostate cancer survivorship research is of increasing importance for patients, medical providers, and other key stakeholders. This manuscript harmonizes a path forward for improving prostate cancer survivorship by defining prostate cancer survivorship and survivorship research, as well as by highlighting key research priorities and cooperative mechanisms for survivorship studies within prostate cancer, with a particular focus on men with advanced disease.

Full Text

Duke Authors

Cited Authors

  • Narayan, V; Harrison, M; Cheng, H; Kenfield, S; Aggarwal, R; Kwon, D; McKay, R; Hauger, R; Hart, N; Conzen, S; Borno, H; Jim, H; Dicker, A; Dorff, T; Moslehi, J; Mucci, L; Parsons, JK; Saad, F; Soule, H; Morgans, A; Ryan, CJ

Published Date

  • March 2020

Published In

Volume / Issue

  • 38 / 3

Start / End Page

  • 83 - 93

PubMed ID

  • 31734020

Electronic International Standard Serial Number (EISSN)

  • 1873-2496

Digital Object Identifier (DOI)

  • 10.1016/j.urolonc.2019.10.006


  • eng

Conference Location

  • United States